Blood Res.  2017 Mar;52(1):69-71. 10.5045/br.2017.52.1.69.

Is N-acetylcysteine infusion an effective treatment option in L-asparaginase associated hepatotoxicity?

• Özdemir Z
• Turhan AB
• Eren M
• Bor O

• KMID: 2375209
• DOI: http://doi.org/10.5045/br.2017.52.1.69

Abstract

No abstract available.

MeSH Terms

Acetylcysteine*
Acetylcysteine

Figure

• 

  Fig. 1 Abdominal computed tomography showed a hepatomegaly and hepatosteatosis.

• 

  Fig. 2 Therapeutic agents used and changes in AST, ALT and ALP.Abbreviations: ALT, alanine transaminase; ALP, alkaline phosphatase; AST, aspartate transaminase; L-Asp, L-asparaginase; NAC, N-acetylcysteine.

Reference

1. Clavell LA, Gelber RD, Cohen HJ, et al. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med. 1986; 315:657–663. PMID: 2943992.

2. Roesmann A, Afify M, Panse J, Eisert A, Steitz J, Tolba RH. L-carnitine ameliorates L-asparaginase-induced acute liver toxicity in steatotic rat livers. Chemotherapy. 2013; 59:167–175. PMID: 24192517.

3. Alshiekh-Nasany R, Douer D. L-Carnitine for treatment of pegasparaginase-induced hepatotoxicity. Acta Haematol. 2016; 135:208–210. PMID: 26841296.

4. Al-Nawakil C, Willems L, Mauprivez C, et al. Successful treatment of L-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors. Leuk Lymphoma. 2014; 55:1670–1674. PMID: 24090500.

5. Pratt CB, Johnson WW. Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy. Cancer. 1971; 28:361–364. PMID: 5109448.

6. Durden DL, Salazar AM, Distasio JA. Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases. Cancer Res. 1983; 43:1602–1605. PMID: 6339039.

7. Tsuji F, Miyake Y, Aono H, Kawashima Y, Mita S. Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin Exp Immunol. 1999; 115:26–31. PMID: 9933417.

8. Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program. 2006; 375–380. PMID: 17124086.

9. Nazer LH, Nazer HM. Drug-induced liver injury. In : Elzouki AY, Harfi HA, Nazer H, Oh W, Stapleton FB, Whitley RJ, editors. Textbook of clinical pediatrics. 2nd ed. New York, NY: Springer;2012. p. 2113–2117.

10. Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins;1999. p. 673–709.

11. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002; 65:166–176. PMID: 11812920.

12. Marí M, Morales A, Colell A, García-Ruiz C, Kaplowitz N, Fernandez-Checa JC. Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta. 2013; 1830:3317–3328. PMID: 23123815.

13. Baumgardner JN, Shankar K, Hennings L, Albano E, Badger TM, Ronis MJ. N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr. 2008; 138:1872–1879. PMID: 18806095.

14. Samuhasaneeto S, Thong-Ngam D, Kulaputana O, Patumraj S, Klaikeaw N. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis. J Med Assoc Thai. 2007; 90:788–797. PMID: 17487136.

15. Kaya I, Citil M, Sozmen M, Karapehlivan M, Cigsar G. Investigation of protective effect of L-carnitine on L-asparaginase-induced acute pancreatic injury in male Balb/c mice. Dig Dis Sci. 2015; 60:1290–1296. PMID: 25502333.